{"id":"W4414167602","doi":"10.1002/ehf2.15393","title":"Empagliflozin After Myocardial Infarction with or without diabetes and chronic kidney disease: Insights from EMPACT-MI","year":2025,"lang":"en","type":"article","venue":"ESC Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Manitoba; Canadian VIGOUR Centre; University of Alberta; University Health Network; Women's College Hospital","funders":"American Regent; Abbott Vascular; Esperion Therapeutics; Daiichi Sankyo Europe; Servier; Vifor Pharma; Universitair Medisch Centrum Groningen; University of Toronto; Bayer HealthCare; Sanofi; Abiomed; Horizon Therapeutics; Pfizer; York University; Moderna; Idorsia Pharmaceuticals; Impulse Dynamics; Novo Nordisk; MyoKardia; Norgine; Novavax; ZOLL Medical Corporation; National Institutes of Health; Regeneron Pharmaceuticals; Boston Scientific Corporation; Cleveland Clinic; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; CSL Behring; Duke Clinical Research Institute; Astellas Pharma; Cytokinetics; HLS Therapeutics; GlaxoSmithKline; LivaNova; Heart and Stroke Foundation of Canada; Amgen; Patient-Centered Outcomes Research Institute","keywords":"Empagliflozin; Myocardial infarction; Diabetes mellitus; Heart failure; Kidney disease; Type 2 diabetes","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002577444,0.0003538079,0.001046004,0.000447878,0.00009604891,0.000740736,0.0002553943,0.000325551,0.0009283292],"category_scores_gemma":[0.004473291,0.0001189811,0.0009529795,0.000470194,0.0001621777,0.0003733791,0.0004904495,0.0008270965,0.0001194347],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004539572,"about_ca_system_score_gemma":0.0006564442,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009633945,"about_ca_topic_score_gemma":0.001764569,"domain_scores_codex":[0.9993325,0.0003155999,0.00003972538,0.00007411958,0.0001865383,0.00005150468],"domain_scores_gemma":[0.9982675,0.0009159931,0.0004350975,0.00005731927,0.000168754,0.000155359],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02708301,0.001594548,0.2211143,0.004396676,0.007677368,0.0006149651,0.00021823,0.00255662,0.002318225,0.002533523,0.01848122,0.7114114],"study_design_scores_gemma":[0.01406714,0.01339605,0.8937572,0.002627984,0.01075379,0.00233364,0.000211459,0.01176454,0.001079821,0.007035018,0.0428758,0.00009742352],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5844015,0.3823199,0.004684381,0.01338937,0.000584746,0.0002785979,0.002556314,0.00008201363,0.01170307],"genre_scores_gemma":[0.8968261,0.0886535,0.004050442,0.004764054,0.002434377,0.0002196058,0.001780228,0.00001831972,0.001253308],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002577444,"threshold_uncertainty_score":0.01363099,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.004717815387064102,"score_gpt":0.2305960315706345,"score_spread":0.2258782161835704,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}